Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,950 | -48,560 | -34,620 | -22,380 | -9,850 |
| Depreciation Amortization | 870 | 2,390 | 1,630 | 1,120 | 560 |
| Other Working Capital | -1,220 | 5,970 | 3,550 | 2,310 | 10 |
| Other Operating Activity | 2,250 | 6,720 | 5,230 | 3,770 | 2,150 |
| Operating Cash Flow | $-11,050 | $-33,480 | $-24,210 | $-15,180 | $-7,130 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -390 | -340 | -210 | -50 |
| Other Investing Activity | -2,570 | 34,670 | 24,500 | 20,990 | 13,600 |
| Investing Cash Flow | $-2,580 | $34,280 | $24,160 | $20,780 | $13,550 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | -500 | -250 | -250 | 0 |
| Other Financing Activity | -1,970 | 14,510 | 16,490 | -1,990 | -940 |
| Financing Cash Flow | $-1,970 | $14,010 | $16,240 | $-2,240 | $-940 |
| Beginning Cash Position | 44,140 | 29,330 | 29,330 | 29,330 | 29,330 |
| End Cash Position | 28,540 | 44,140 | 45,520 | 32,700 | 34,810 |
| Net Cash Flow | $-15,600 | $14,800 | $16,190 | $3,360 | $5,470 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,050 | -33,480 | -24,210 | -15,180 | -7,130 |
| Free Cash Flow | -11,050 | -33,480 | -24,210 | -15,180 | -7,130 |